Previous studies have suggested that a drug indicated for treating rheumatoid arthritis may increase the risk for blood clots. In a new study, researchers assessed this risk further.
Previous studies have suggested that a drug indicated for treating rheumatoid arthritis may increase the risk for blood clots. In a new study, researchers assessed this risk further.
Previous evidence has suggested that vitamin D may play a role in chronic non-specific widespread pain, which is associated with disability and reduced quality of life. A new study assessed this association...
The Cardiometabolic Risk Summit (CRS), powered by Consultant and designed by expert leaders in primary care and cardiometabolic risk management, took place October 20-22 at the Hyatt Regency Dallas.
The Cardiometabolic Risk Summit (CRS), powered by Consultant and designed by expert leaders in primary care and cardiometabolic risk management, took place October 20-22 at the Hyatt Regency Dallas.
The Cardiometabolic Risk Summit (CRS), powered by Consultant and designed by expert leaders in primary care and cardiometabolic risk management, took place October 20-22 at the Hyatt Regency Dallas.
The Cardiometabolic Risk Summit (CRS), powered by Consultant and designed by expert leaders in primary care and cardiometabolic risk management, took place October 20-22 at the Hyatt Regency Dallas.
Michael J Bloch will discuss the appropriate incorporation of PCSK9 inhibitors for the lowering of LDL-C in patients with hypercholesterolemia in his upcoming presentation, “Advancing Hyperlipidemia...
Michael J Bloch will discuss the appropriate incorporation of PCSK9 inhibitors for the lowering of LDL-C in patients with hypercholesterolemia in his upcoming presentation, “Advancing Hyperlipidemia...
Michael J Bloch will discuss the appropriate incorporation of PCSK9 inhibitors for the lowering of LDL-C in patients with hypercholesterolemia in his upcoming presentation, “Advancing Hyperlipidemia...
